Dr. Senthil is a surgical oncologist and Peritoneal malignancy surgeon with a special expertise in the management of patients with advanced gastric cancer and peritoneal carcinomatosis Dr. Senthil did her medical school training at Madurai Medical college, India and subsequently completed her surgical training at University of Medicine dentistry, New Jersey and Surgical Oncology fellowship training at City of Hope. Dr. Senthil is the Chief of Division of Surgical Oncology, John Wayne Cancer Foundation endowed chair, and the Director of Peritoneal Malignancy program at University of California-Irvine. Dr. Senthil is also the founding program director of two complex general surgical oncology fellowships; Loma Linda University Health in 2015 and University of California, Irvine in 2021. She has received numerous awards for her commitment and dedication to educational excellence; Golden Apple award, Arnold P. Gold award for Humanism and excellence in teaching, and John Connolly Teacher of the year award. Dr. Senthil has a comprehensive research program that spans the spectrum of clinical trials, translational research, radiomics, and cancer disparities. She is the PI of STOPGAP clinical trial (NCT04762953), a phase II clinical trial that is evaluating the role of sequential systemic chemotherapy and normothermic intraperitoneal chemotherapy (NIPEC) followed by cytoreduction/Hyperthermic intraperitoneal chemotherapy( HIPEC) in patients with gastric/ GEJ cancer with peritoneal carcinomatosis.